| Field | Row 1 | Row 2 |
|---|---|---|
| adsh | 0001829126-25-003897 | 0001829126-25-002289 |
| cik | 1859035 | 1859035 |
| name | MOUNTAIN CREST ACQUISITION CORP. V | MOUNTAIN CREST ACQUISITION CORP. V |
| sic | 3841 | 3841 |
| countryba | US | US |
| stprba | NY | NY |
| cityba | NEW YORK | NEW YORK |
| zipba | 10012 | 10012 |
| bas1 | 524 BROADWAY | 524 BROADWAY |
| bas2 | 11TH FLOOR | 11TH FLOOR |
| baph | 646-493-6558 | 646-493-6558 |
| countryma | US | US |
| stprma | NY | NY |
| cityma | NEW YORK | NEW YORK |
| zipma | 10012 | 10012 |
| mas1 | 524 BROADWAY | 524 BROADWAY |
| mas2 | 11TH FLOOR | 11TH FLOOR |
| countryinc | US | US |
| stprinc | DE | DE |
| ein | 000000000 | 000000000 |
| former | ||
| changed | ||
| afs | 4-NON | 4-NON |
| wksi | 0 | 0 |
| fye | 1231 | 1231 |
| form | 10-Q | 10-K |
| period | 20250331 | 20241231 |
| fy | 2025 | 2024 |
| fp | Q1 | FY |
| filed | 20250522 | 20250401 |
| accepted | 2025-05-22 16:45:00.0 | 2025-04-01 16:33:00.0 |
| prevrpt | 0 | 0 |
| detail | 1 | 1 |
| instance | mountaincrest5_10q_htm.xml | mountaincrest5_10k_htm.xml |
| nciks | 1 | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0001829126-25-002289 | 20231231 | Additional Paid In Capital | 1946827.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20231231 | Cash Withdrawn From Trust Account In Connection With Redemption | 14692409.0000 | USD | 4 | 0001829126-25-002289 | |||
| 0001829126-25-002289 | 20231231 | Conversion Of Accounts Payable To Promissory Notes | 102877.0000 | USD | 4 | 0001829126-25-002289 | |||
| 0001829126-25-002289 | 20231231 | Excise Tax Payable Attributable To Redemption Of Common Stock | -146924.0000 | USD | 4 | 0001829126-25-002289 | |||
| 0001829126-25-002289 | 20241231 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -328558.0000 | USD | 4 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20241231 | Increase Decrease In Accounts Payable And Accrued Liabilities | -224169.0000 | USD | 4 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20241231 | Increase Decrease In Income Taxes | -5096.0000 | USD | 4 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20231231 | Increase Decrease In Other Accounts Payable And Accrued Liabilities | USD | 4 | us-gaap/2024 | ||||
| 0001829126-25-002289 | 20241231 | Increase Decrease In Other Accounts Payable And Accrued Liabilities | 9167.0000 | USD | 4 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20231231 | Net Cash Provided By Used In Investing Activities | 14469765.0000 | USD | 4 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20231231 | Nonoperating Income Expense | 505141.0000 | USD | 4 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20231231 | Operating Income Loss | -2654975.0000 | USD | 4 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20231231 | Prepaid Expense Current | USD | 0 | us-gaap/2024 | ||||
| 0001829126-25-002289 | 20231231 | Proceeds From Related Party Debt | 200000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20241231 | Proceeds From Related Party Debt | 1090000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20231231 | Stockholders Equity | -5244248.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001829126-25-002289 | 20241231 | Stockholders Equity | 2225421.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001829126-25-002289 | 20231231 | Temporary Equity Shares Authorized | 519321.0000 | shares | 0 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20231231 | Weighted Average Shares Outstanding Of Nonredeemable Common Stock | 2284119.0000 | shares | 4 | 0001829126-25-002289 | |||
| 0001829126-25-003897 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 16089.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -88715.0000 | USD | 1 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20241231 | Common Stock Shares Authorized | 30000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20250331 | Common Stock Shares Outstanding | 2800900.0000 | shares | 0 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20240331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -11239.0000 | USD | 1 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20250331 | Income Tax Expense Benefit | 2272.0000 | USD | 1 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20240331 | Increase Decrease In Accrued Taxes Payable | USD | 1 | us-gaap/2024 | ||||
| 0001829126-25-003897 | 20250331 | Interest Expense | USD | 1 | us-gaap/2024 | ||||
| 0001829126-25-003897 | 20240331 | Interest Income Operating | 73585.0000 | USD | 1 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20250331 | Investments Held In Trust Account | 1169431.0000 | USD | 0 | 0001829126-25-003897 | |||
| 0001829126-25-003897 | 20241231 | Liabilities And Stockholders Equity | 1314091.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20241231 | Liabilities Current | 1520579.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20250331 | Net Cash Provided By Used In Financing Activities | USD | 1 | us-gaap/2024 | ||||
| 0001829126-25-003897 | 20250331 | Operating Income Loss | -191225.0000 | USD | 1 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20250331 | Profit Loss | -181378.0000 | USD | 1 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20241231 | Promissory Note Related Party | 690000.0000 | USD | 0 | 0001829126-25-003897 | |||
| 0001829126-25-003897 | 20231231 | Stockholders Equity | -5244248.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001829126-25-003897 | 20240331 | Stockholders Equity | 266.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001829126-25-003897 | 20250331 | Stockholders Equity | 2222629.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001829126-25-002289 | 20231231 | Accretion For Common Stock Subject To Redemptions Amount | 721605.0000 | USD | 4 | 0001829126-25-002289 | |||
| 0001829126-25-002289 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20210331 | Common Stock Shares Outstanding | 1437500.0000 | shares | 0 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20231231 | Common Stock Value | 266.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20231231 | Conversion Of Promissory Note Payable | 299992.0000 | USD | 4 | 0001829126-25-002289 | Equity Components= Additional Paid In Capital; | ||
| 0001829126-25-002289 | 20241231 | Conversion Of Promissory Note Payable | 600000.0000 | USD | 4 | 0001829126-25-002289 | |||
| 0001829126-25-002289 | 20241231 | Conversion Of Promissory Note Payable | 15.0000 | USD | 4 | 0001829126-25-002289 | Equity Components= Common Stock; | ||
| 0001829126-25-002289 | 20241231 | Conversion Of Promissory Note Payable | USD | 4 | 0001829126-25-002289 | Equity Components= Retained Earnings; | |||
| 0001829126-25-002289 | 20231231 | Excise Tax Payable Attributable To Redemption Of Common Stock | USD | 4 | 0001829126-25-002289 | Equity Components= Additional Paid In Capital; | |||
| 0001829126-25-002289 | 20241231 | Excise Tax Payable Attributable To Redemption Of Common Stock | -47367.0000 | USD | 4 | 0001829126-25-002289 | Equity Components= Retained Earnings; | ||
| 0001829126-25-002289 | 20231231 | Increase Decrease In Accounts Payable And Accrued Liabilities | 2165436.0000 | USD | 4 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20231231 | Increase Decrease In Prepaid Expense | -11430.0000 | USD | 4 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20241231 | Increase Decrease In Prepaid Expenses Other | 9167.0000 | USD | 4 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20231231 | Interest Expense | 5587.0000 | USD | 4 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20231231 | Investment Of Cash Into Trust Account | 351932.0000 | USD | 4 | 0001829126-25-002289 | |||
| 0001829126-25-002289 | 20241231 | Profit Loss | USD | 4 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001829126-25-002289 | 20241231 | Promissory Note | 0.0000 | USD | 0 | 0001829126-25-002289 | |||
| 0001829126-25-002289 | 20231231 | Redemption Of Common Stock | 14692409.0000 | USD | 4 | 0001829126-25-002289 | |||
| 0001829126-25-002289 | 20231231 | Stockholders Equity | -3297155.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20231231 | Stockholders Equity | 266.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001829126-25-002289 | 20241231 | Stockholders Equity | -3440367.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20241231 | Stockholders Equity | 281.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001829126-25-002289 | 20241231 | Taxes Payable Current | 284492.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20241231 | Temporary Equity Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20240331 | Accounts Payable And Accrued Expenses | 60750.0000 | USD | 1 | 0001829126-25-003897 | |||
| 0001829126-25-003897 | 20241231 | Accounts Payable And Accrued Liabilities Current | 348395.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20250331 | Accounts Payable And Accrued Liabilities Current | 414524.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20240331 | Accretion For Common Stock Subject To Redemption Amount | USD | 1 | 0001829126-25-003897 | Equity Components= Retained Earnings; | |||
| 0001829126-25-003897 | 20250331 | Accretion For Common Stock Subject To Redemption Amount | USD | 1 | 0001829126-25-003897 | Equity Components= Retained Earnings; | |||
| 0001829126-25-003897 | 20240331 | Basic And Diluted Net Loss Per Share Nonredeemable Common Stock | -0.0400 | USD | 1 | 0001829126-25-003897 | |||
| 0001829126-25-003897 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20210531 | Common Stock Shares Outstanding | 1437500.0000 | shares | 0 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20250331 | Investment Of Cash Into Trust Account | USD | 1 | 0001829126-25-003897 | ||||
| 0001829126-25-003897 | 20250331 | Profit Loss | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001829126-25-003897 | 20250331 | Retained Earnings Accumulated Deficit | -5847447.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20241231 | Shares Outstanding | 2800900.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001829126-25-003897 | 20231231 | Stockholders Equity | -3297155.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20231231 | Stockholders Equity | 266.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001829126-25-003897 | 20241231 | Temporary Equity Redemption Price Per Share | 11.5100 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20241231 | Temporary Equity Shares Authorized | 101104.0000 | shares | 0 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20231231 | Assets | 5629484.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20231231 | Assets Current | 16089.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20231231 | Basic And Diluted Loss Income Per Share Redeemable Common Stock | -0.2000 | USD | 4 | 0001829126-25-002289 | |||
| 0001829126-25-002289 | 20221231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 259408.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | 100569.0000 | USD | 4 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20241231 | Cash Withdrawn From Trust Account In Connection With Redemption | 4736743.0000 | USD | 4 | 0001829126-25-002289 | |||
| 0001829126-25-002289 | 20231231 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20231231 | Common Stock Shares Authorized | 30000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20210531 | Common Stock Shares Issued | 1437500.0000 | shares | 0 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20231231 | Conversion Of Vendor Liability | 1799955.0000 | USD | 4 | 0001829126-25-002289 | Equity Components= Additional Paid In Capital; | ||
| 0001829126-25-002289 | 20231231 | Conversions Of Vendor Liability | 1800000.0000 | USD | 4 | 0001829126-25-002289 | |||
| 0001829126-25-002289 | 20231231 | Deferred Compensation Liability Classified Noncurrent | 2070000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20241231 | Excise Tax Payable Attributable To Redemption Of Common Stock | USD | 4 | 0001829126-25-002289 | Equity Components= Additional Paid In Capital; | |||
| 0001829126-25-002289 | 20231231 | Excise Tax Payables Attributable To Redemption Of Common Stock | 146924.0000 | USD | 4 | 0001829126-25-002289 | |||
| 0001829126-25-002289 | 20241231 | Gains Losses On Extinguishment Of Debt | 26024.0000 | USD | 4 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20231231 | General And Administrative Expense | 2654975.0000 | USD | 4 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20241231 | General And Administrative Expense | 618486.0000 | USD | 4 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20231231 | Income Tax Expense Benefit | 101282.0000 | USD | 4 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20231231 | Interest Earned On Investments Held In Trust Account | 510728.0000 | USD | 4 | 0001829126-25-002289 | |||
| 0001829126-25-002289 | 20241231 | Interest Expense | 1402.0000 | USD | 4 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20241231 | Liabilities | 3590579.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20231231 | Proceeds From Convertible Debt | 300000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20241231 | Proceeds From Convertible Debt | USD | 4 | us-gaap/2024 | ||||
| 0001829126-25-002289 | 20231231 | Profit Loss | USD | 4 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001829126-25-002289 | 20241231 | Profit Loss | -374454.0000 | USD | 4 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20241231 | Profit Loss | USD | 4 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001829126-25-002289 | 20231231 | Shares Outstanding | 2650900.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001829126-25-002289 | 20221231 | Stockholders Equity | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001829126-25-002289 | 20221231 | Stockholders Equity | 213.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001829126-25-002289 | 20231231 | Stockholders Equity | 1946827.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001829126-25-002289 | 20241231 | Temporary Equity Carrying Amount Attributable To Parent | 1163879.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20231231 | Temporary Equity Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20241231 | Temporary Equity Shares Authorized | 101104.0000 | shares | 0 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20241231 | Weighted Average Shares Outstanding Of Nonredeemable Common Stock | 2755818.0000 | shares | 4 | 0001829126-25-002289 | |||
| 0001829126-25-003897 | 20240331 | Accretion For Common Stock Subject To Redemption Amount | USD | 1 | 0001829126-25-003897 | Equity Components= Common Stock; | |||
| 0001829126-25-003897 | 20240331 | Basic And Diluted Loss Income Per Share Redeemable Common Stock | 0.1600 | USD | 1 | 0001829126-25-003897 | |||
| 0001829126-25-003897 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 23813.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20241231 | Common Stock Value | 281.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20240331 | Increase Decrease In Accounts Payable And Accrued Liabilities | -2920.0000 | USD | 1 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20240331 | Net Cash Provided By Used In Financing Activities | 190000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20250331 | Profit Loss | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001829126-25-003897 | 20241231 | Sales And Excise Tax Payable Current | 197692.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20241231 | Taxes Payable Current | 284492.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20250331 | Temporary Equity Carrying Amount Attributable To Parent | 1166671.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20250331 | Temporary Equity Redemption Price Per Share | 11.5400 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20250331 | Accretion For Common Stock Subject To Redemption Amount | -2792.0000 | USD | 1 | 0001829126-25-003897 | |||
| 0001829126-25-002289 | 20241231 | Accounts Payable And Accrued Liabilities Current | 348395.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20241231 | Accretion For Common Stock Subject To Redemption Amount | USD | 4 | 0001829126-25-002289 | Equity Components= Retained Earnings; | |||
| 0001829126-25-002289 | 20231231 | Assets Held In Trust | 5613395.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20231231 | Basic And Diluted Net Loss Per Share Nonredeemable Common Stock | -0.9000 | USD | 4 | 0001829126-25-002289 | |||
| 0001829126-25-002289 | 20241231 | Cash Withdrawn From Trust Account To Pay Franchise And Income Taxes | 140442.0000 | USD | 4 | 0001829126-25-002289 | |||
| 0001829126-25-002289 | 20241231 | Common Stock Value | 281.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20241231 | Conversion Of Accounts Payable To Promissory Notes | USD | 4 | 0001829126-25-002289 | ||||
| 0001829126-25-002289 | 20241231 | Conversion Of Convertible Promissory Note Related Party | 600000.0000 | USD | 4 | 0001829126-25-002289 | |||
| 0001829126-25-002289 | 20231231 | Conversion Of Promissory Note Payable | 8.0000 | USD | 4 | 0001829126-25-002289 | Equity Components= Common Stock; | ||
| 0001829126-25-002289 | 20231231 | Conversion Of Promissory Note Payable | USD | 4 | 0001829126-25-002289 | Equity Components= Retained Earnings; | |||
| 0001829126-25-002289 | 20231231 | Conversion Of Promissory Note Payable Shares | 75000.0000 | shares | 4 | 0001829126-25-002289 | Equity Components= Common Stock; | ||
| 0001829126-25-002289 | 20231231 | Gains Losses On Extinguishment Of Debt | USD | 4 | us-gaap/2024 | ||||
| 0001829126-25-002289 | 20241231 | Income Tax Expense Benefit | 45896.0000 | USD | 4 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20231231 | Increase Decrease In Income Taxes | 108716.0000 | USD | 4 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20231231 | Interest Income Operating | 510728.0000 | USD | 4 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20231231 | Liabilities Current | 1277408.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20241231 | Net Cash Provided By Used In Financing Activities | -3699620.0000 | USD | 4 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20241231 | Net Income Loss | -374454.0000 | USD | 4 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20231231 | Profit Loss | -2251116.0000 | USD | 4 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001829126-25-002289 | 20231231 | Promissory Note | 52877.0000 | USD | 0 | 0001829126-25-002289 | |||
| 0001829126-25-002289 | 20241231 | Redemption Of Common Stock | 4736743.0000 | USD | 4 | 0001829126-25-002289 | |||
| 0001829126-25-002289 | 20241231 | Retained Earnings Accumulated Deficit | -5666069.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20231231 | Temporary Equity Redemption Price Per Share | 10.7400 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20250331 | Accretion For Common Stock Subject To Redemptions Amount | 2792.0000 | USD | 1 | 0001829126-25-003897 | |||
| 0001829126-25-003897 | 20250331 | Additional Paid In Capital | 2222629.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20250331 | Common Stock Shares Authorized | 30000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20241231 | Deferred Underwriting Fee Payable | 2070000.0000 | USD | 0 | 0001829126-25-003897 | |||
| 0001829126-25-003897 | 20250331 | Increase Decrease In Accounts Payable And Accrued Liabilities | 59462.0000 | USD | 1 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20240331 | Increase Decrease In Accrued Income Taxes Payable | 14298.0000 | USD | 1 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20250331 | Increase Decrease In Accrued Income Taxes Payable | 8027.0000 | USD | 1 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20240331 | Interest Earned On Investments Held In Trust Account | 73585.0000 | USD | 1 | 0001829126-25-003897 | |||
| 0001829126-25-003897 | 20250331 | Net Cash Provided By Used In Operating Activities | -88715.0000 | USD | 1 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20241231 | Prepaid Expense Current | 40121.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20250331 | Proceeds From Promissory Note Related Party | USD | 1 | 0001829126-25-003897 | ||||
| 0001829126-25-003897 | 20250331 | Sales And Excise Tax Payable Current | 202794.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20231231 | Shares Outstanding | 2650900.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001829126-25-003897 | 20240331 | Stockholders Equity | -3428411.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20240331 | Stockholders Equity | 1841108.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001829126-25-003897 | 20240331 | Stockholders Equity | -5269785.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001829126-25-003897 | 20250331 | Stockholders Equity | -3624537.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20241231 | Temporary Equity Carrying Amount Attributable To Parent | 1163879.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20241231 | Temporary Equity Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20240331 | Accretion For Common Stock Subject To Redemption Amount | -105719.0000 | USD | 1 | 0001829126-25-003897 | |||
| 0001829126-25-002289 | 20231231 | Accounts Payable And Accrued Liabilities Current | 582432.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20231231 | Accretion For Common Stock Subject To Redemption Amount | -568485.0000 | USD | 4 | 0001829126-25-002289 | Equity Components= Retained Earnings; | ||
| 0001829126-25-002289 | 20241231 | Accretion For Common Stock Subject To Redemption Amount | USD | 4 | 0001829126-25-002289 | Equity Components= Common Stock; | |||
| 0001829126-25-002289 | 20241231 | Assets | 1314091.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20231231 | Cash | 16089.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20241231 | Cash | 116658.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 16089.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -243319.0000 | USD | 4 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20241231 | Common Stock Shares Authorized | 30000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20231231 | Common Stock Shares Issued | 2650900.0000 | shares | 0 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20231231 | Conversion Of Vendor Liability | USD | 4 | 0001829126-25-002289 | Equity Components= Retained Earnings; | |||
| 0001829126-25-002289 | 20241231 | Deferred Compensation Liability Classified Noncurrent | 2070000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20231231 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -2149834.0000 | USD | 4 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20231231 | Liabilities And Stockholders Equity | 5629484.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20241231 | Liabilities Current | 1520579.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20231231 | Net Cash Provided By Used In Operating Activities | -470675.0000 | USD | 4 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20231231 | Profit Loss | -2251116.0000 | USD | 4 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20231231 | Profit Loss | USD | 4 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001829126-25-002289 | 20241231 | Promissory Note Related Party | 690000.0000 | USD | 0 | 0001829126-25-002289 | |||
| 0001829126-25-002289 | 20231231 | Repayments Of Debt | 50000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20221231 | Stockholders Equity | -2277510.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20250331 | Accounts Payable And Accrued Expenses | 6667.0000 | USD | 1 | 0001829126-25-003897 | |||
| 0001829126-25-003897 | 20240331 | Accretion For Common Stock Subject To Redemptions Amount | 105719.0000 | USD | 1 | 0001829126-25-003897 | |||
| 0001829126-25-003897 | 20241231 | Additional Paid In Capital | 2225421.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20241231 | Assets Current | 156779.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | 7724.0000 | USD | 1 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20211130 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | Subsidiary Sale Of Stock= I P O; | ||
| 0001829126-25-003897 | 20250331 | Common Stock Value | 281.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20240331 | General And Administrative Expense | 83769.0000 | USD | 1 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20250331 | Increase Decrease In Prepaid Expense | -32191.0000 | USD | 1 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20241231 | Liabilities | 3590579.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20250331 | Net Cash Provided By Used In Investing Activities | USD | 1 | us-gaap/2024 | ||||
| 0001829126-25-003897 | 20240331 | Net Cash Provided By Used In Operating Activities | -130344.0000 | USD | 1 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20250331 | Nonoperating Income Expense | 12119.0000 | USD | 1 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20240331 | Profit Loss | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001829126-25-003897 | 20240331 | Profit Loss | -25537.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001829126-25-003897 | 20241231 | Retained Earnings Accumulated Deficit | -5666069.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20231231 | Stockholders Equity | 1946827.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001829126-25-003897 | 20241231 | Stockholders Equity | 2225421.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001829126-25-003897 | 20241231 | Stockholders Equity | -5666069.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001829126-25-003897 | 20250331 | Stockholders Equity | -5847447.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001829126-25-003897 | 20250331 | Weighted Average Shares Outstanding Of Nonredeemable Common Stock | 2800900.0000 | shares | 1 | 0001829126-25-003897 | |||
| 0001829126-25-003897 | 20240331 | Weighted Average Shares Outstanding Of Redeemable Common Stock | 519321.0000 | shares | 1 | 0001829126-25-003897 | |||
| 0001829126-25-002289 | 20231231 | Accretion For Common Stock Subject To Redemption Amount | USD | 4 | 0001829126-25-002289 | Equity Components= Common Stock; | |||
| 0001829126-25-002289 | 20231231 | Cash Withdrawn From Trust Account To Pay Franchise And Income Taxes | 129288.0000 | USD | 4 | 0001829126-25-002289 | |||
| 0001829126-25-002289 | 20231231 | Common Stock Shares Outstanding | 2650900.0000 | shares | 0 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20231231 | Conversion Of Vendor Liability | 1800000.0000 | USD | 4 | 0001829126-25-002289 | |||
| 0001829126-25-002289 | 20241231 | Conversions Of Vendor Liability | USD | 4 | 0001829126-25-002289 | ||||
| 0001829126-25-002289 | 20231231 | Excise Tax Payable Attributable To Redemption Of Common Stock | USD | 4 | 0001829126-25-002289 | Equity Components= Common Stock; | |||
| 0001829126-25-002289 | 20231231 | Excise Tax Payable Attributable To Redemption Of Common Stock | -146924.0000 | USD | 4 | 0001829126-25-002289 | Equity Components= Retained Earnings; | ||
| 0001829126-25-002289 | 20241231 | Increase Decrease In Accrued Taxes Payable | 3401.0000 | USD | 4 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20231231 | Increase Decrease In Prepaid Expenses Other | USD | 4 | us-gaap/2024 | ||||
| 0001829126-25-002289 | 20231231 | Interest Payable Current | 5587.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20241231 | Interest Payable Current | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20241231 | Investment Of Cash Into Trust Account | 155796.0000 | USD | 4 | 0001829126-25-002289 | |||
| 0001829126-25-002289 | 20241231 | Liabilities And Stockholders Equity | 1314091.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20241231 | Net Cash Provided By Used In Operating Activities | -921200.0000 | USD | 4 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20241231 | Operating Income Loss | -618486.0000 | USD | 4 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20241231 | Prepaid Expense Current | 40121.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20241231 | Repayments Of Debt | 52877.0000 | USD | 4 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20231231 | Retained Earnings Accumulated Deficit | -5244248.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20231231 | Sales And Excise Tax Payable Current | 146924.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20221231 | Shares Outstanding | 2125900.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001829126-25-002289 | 20241231 | Temporary Equity Redemption Price Per Share | 11.5100 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20250331 | Accretion For Common Stock Subject To Redemption Amount | -2792.0000 | USD | 1 | 0001829126-25-003897 | Equity Components= Additional Paid In Capital; | ||
| 0001829126-25-003897 | 20250331 | Accretion For Common Stock Subject To Redemption Amount | USD | 1 | 0001829126-25-003897 | Equity Components= Common Stock; | |||
| 0001829126-25-003897 | 20241231 | Cash | 116658.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20250331 | Cash | 27943.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20240331 | Income Tax Expense Benefit | 14298.0000 | USD | 1 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20241231 | Investments Held In Trust Account | 1157312.0000 | USD | 0 | 0001829126-25-003897 | |||
| 0001829126-25-003897 | 20250331 | Liabilities | 3669837.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20250331 | Liabilities Current | 1599837.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20250331 | Net Income Loss | -181378.0000 | USD | 1 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20240331 | Nonoperating Income Expense | 72530.0000 | USD | 1 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20240331 | Proceeds From Promissory Note Related Party | 190000.0000 | USD | 1 | 0001829126-25-003897 | |||
| 0001829126-25-003897 | 20240331 | Profit Loss | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001829126-25-003897 | 20250331 | Profit Loss | -181378.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001829126-25-003897 | 20240331 | Shares Outstanding | 2650900.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001829126-25-003897 | 20250331 | Taxes Payable Current | 292519.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20240331 | Weighted Average Shares Outstanding Of Nonredeemable Common Stock | 2650900.0000 | shares | 1 | 0001829126-25-003897 | |||
| 0001829126-25-003897 | 20250331 | Weighted Average Shares Outstanding Of Redeemable Common Stock | 101104.0000 | shares | 1 | 0001829126-25-003897 | |||
| 0001829126-25-002289 | 20231231 | Accretion For Common Stock Subject To Redemption Amount | -153120.0000 | USD | 4 | 0001829126-25-002289 | Equity Components= Additional Paid In Capital; | ||
| 0001829126-25-002289 | 20241231 | Accretion For Common Stock Subject To Redemption Amount | -321391.0000 | USD | 4 | 0001829126-25-002289 | |||
| 0001829126-25-002289 | 20241231 | Accretion For Common Stock Subject To Redemptions Amount | 321391.0000 | USD | 4 | 0001829126-25-002289 | |||
| 0001829126-25-002289 | 20241231 | Additional Paid In Capital | 2225421.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20241231 | Assets Current | 156779.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20241231 | Basic And Diluted Loss Income Per Share Redeemable Common Stock | 0.4800 | USD | 4 | 0001829126-25-002289 | |||
| 0001829126-25-002289 | 20241231 | Common Stock Shares Issued | 2800900.0000 | shares | 0 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20210531 | Common Stock Shares Outstanding | 1437500.0000 | shares | 0 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20241231 | Common Stock Shares Outstanding | 2800900.0000 | shares | 0 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20231231 | Conversion Of Convertible Promissory Note Related Party | 300000.0000 | USD | 4 | 0001829126-25-002289 | |||
| 0001829126-25-002289 | 20241231 | Conversion Of Promissory Note Payable | 599985.0000 | USD | 4 | 0001829126-25-002289 | Equity Components= Additional Paid In Capital; | ||
| 0001829126-25-002289 | 20231231 | Conversion Of Vendor Liability | 45.0000 | USD | 4 | 0001829126-25-002289 | Equity Components= Common Stock; | ||
| 0001829126-25-002289 | 20241231 | Excise Tax Payables Attributable To Redemption Of Common Stock | 47367.0000 | USD | 4 | 0001829126-25-002289 | |||
| 0001829126-25-002289 | 20241231 | Increase Decrease In Prepaid Expense | 30954.0000 | USD | 4 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20241231 | Net Cash Provided By Used In Investing Activities | 4721389.0000 | USD | 4 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20241231 | Nonoperating Income Expense | 289928.0000 | USD | 4 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20231231 | Promissory Note Related Party | 200000.0000 | USD | 0 | 0001829126-25-002289 | |||
| 0001829126-25-002289 | 20241231 | Shares Outstanding | 2800900.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001829126-25-002289 | 20221231 | Stockholders Equity | -2277723.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001829126-25-002289 | 20231231 | Taxes Payable Current | 289588.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20241231 | Weighted Average Shares Outstanding Of Redeemable Common Stock | 458760.0000 | shares | 4 | 0001829126-25-002289 | |||
| 0001829126-25-003897 | 20240331 | Accretion For Common Stock Subject To Redemption Amount | -105719.0000 | USD | 1 | 0001829126-25-003897 | Equity Components= Additional Paid In Capital; | ||
| 0001829126-25-003897 | 20241231 | Assets | 1314091.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20250331 | Assets | 1211971.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20250331 | Basic And Diluted Loss Income Per Share Redeemable Common Stock | -0.0400 | USD | 1 | 0001829126-25-003897 | |||
| 0001829126-25-003897 | 20241231 | Common Stock Shares Issued | 2800900.0000 | shares | 0 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20241231 | Common Stock Shares Outstanding | 2800900.0000 | shares | 0 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20250331 | General And Administrative Expense | 191225.0000 | USD | 1 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20250331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -179106.0000 | USD | 1 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20240331 | Interest Expense | 1055.0000 | USD | 1 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20250331 | Interest Income Operating | 12119.0000 | USD | 1 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20240331 | Operating Income Loss | -83769.0000 | USD | 1 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20250331 | Promissory Note Related Party | 690000.0000 | USD | 0 | 0001829126-25-003897 | |||
| 0001829126-25-003897 | 20250331 | Stockholders Equity | 281.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001829126-25-003897 | 20250331 | Temporary Equity Shares Authorized | 101104.0000 | shares | 0 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20231231 | Accretion For Common Stock Subject To Redemption Amount | -721605.0000 | USD | 4 | 0001829126-25-002289 | |||
| 0001829126-25-002289 | 20241231 | Accretion For Common Stock Subject To Redemption Amount | -321391.0000 | USD | 4 | 0001829126-25-002289 | Equity Components= Additional Paid In Capital; | ||
| 0001829126-25-002289 | 20241231 | Assets Held In Trust | 1157312.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20241231 | Basic And Diluted Net Loss Per Share Nonredeemable Common Stock | -0.2200 | USD | 4 | 0001829126-25-002289 | |||
| 0001829126-25-002289 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 116658.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20211130 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | Subsidiary Sale Of Stock= I P O; | ||
| 0001829126-25-002289 | 20231231 | Conversion Of Promissory Note Payable | 300000.0000 | USD | 4 | 0001829126-25-002289 | |||
| 0001829126-25-002289 | 20241231 | Conversion Of Promissory Note Payable Shares | 150000.0000 | shares | 4 | 0001829126-25-002289 | Equity Components= Common Stock; | ||
| 0001829126-25-002289 | 20231231 | Conversion Of Vendor Liability Shares | 450000.0000 | shares | 4 | 0001829126-25-002289 | Equity Components= Common Stock; | ||
| 0001829126-25-002289 | 20241231 | Excise Tax Payable Attributable To Redemption Of Common Stock | -47367.0000 | USD | 4 | 0001829126-25-002289 | |||
| 0001829126-25-002289 | 20241231 | Excise Tax Payable Attributable To Redemption Of Common Stock | USD | 4 | 0001829126-25-002289 | Equity Components= Common Stock; | |||
| 0001829126-25-002289 | 20231231 | Increase Decrease In Accrued Taxes Payable | USD | 4 | us-gaap/2024 | ||||
| 0001829126-25-002289 | 20241231 | Interest Earned On Investments Held In Trust Account | 265306.0000 | USD | 4 | 0001829126-25-002289 | |||
| 0001829126-25-002289 | 20241231 | Interest Income Operating | 265306.0000 | USD | 4 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20231231 | Liabilities | 3347408.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20231231 | Net Cash Provided By Used In Financing Activities | -14242409.0000 | USD | 4 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20231231 | Net Income Loss | -2251116.0000 | USD | 4 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20241231 | Profit Loss | -374454.0000 | USD | 4 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001829126-25-002289 | 20241231 | Sales And Excise Tax Payable Current | 197692.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20241231 | Stockholders Equity | -5666069.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001829126-25-002289 | 20221231 | Temporary Equity Carrying Amount Attributable To Parent | 19550035.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20231231 | Temporary Equity Carrying Amount Attributable To Parent | 5579231.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-002289 | 20231231 | Weighted Average Shares Outstanding Of Redeemable Common Stock | 1029765.0000 | shares | 4 | 0001829126-25-002289 | |||
| 0001829126-25-003897 | 20250331 | Assets Current | 42540.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20250331 | Basic And Diluted Net Loss Per Share Nonredeemable Common Stock | -0.0600 | USD | 1 | 0001829126-25-003897 | |||
| 0001829126-25-003897 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 116658.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 27943.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20210531 | Common Stock Shares Issued | 1437500.0000 | shares | 0 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20250331 | Common Stock Shares Issued | 2800900.0000 | shares | 0 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20250331 | Deferred Underwriting Fee Payable | 2070000.0000 | USD | 0 | 0001829126-25-003897 | |||
| 0001829126-25-003897 | 20250331 | Increase Decrease In Accrued Taxes Payable | 5102.0000 | USD | 1 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20240331 | Increase Decrease In Prepaid Expense | 43655.0000 | USD | 1 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20250331 | Interest Earned On Investments Held In Trust Account | 12119.0000 | USD | 1 | 0001829126-25-003897 | |||
| 0001829126-25-003897 | 20240331 | Investment Of Cash Into Trust Account | 51932.0000 | USD | 1 | 0001829126-25-003897 | |||
| 0001829126-25-003897 | 20250331 | Liabilities And Stockholders Equity | 1211971.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20240331 | Net Cash Provided By Used In Investing Activities | -51932.0000 | USD | 1 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20240331 | Net Income Loss | -25537.0000 | USD | 1 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20250331 | Prepaid Expense Current | 14597.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20240331 | Prepaid Expenses | 60750.0000 | USD | 1 | 0001829126-25-003897 | |||
| 0001829126-25-003897 | 20250331 | Prepaid Expenses | 6667.0000 | USD | 1 | 0001829126-25-003897 | |||
| 0001829126-25-003897 | 20240331 | Profit Loss | -25537.0000 | USD | 1 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20250331 | Shares Outstanding | 2800900.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001829126-25-003897 | 20241231 | Stockholders Equity | -3440367.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003897 | 20241231 | Stockholders Equity | 281.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001829126-25-003897 | 20250331 | Temporary Equity Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Deferred Compensation Liability Classified Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Deferred Compensation Liability, Classified, Noncurrent | Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer). |
| Increase Decrease In Prepaid Expenses Other | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expenses, Other | Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods. |
| Basic And Diluted Net Loss Per Share Nonredeemable Common Stock | 0001829126-25-002289 | 1 | 0 | perShare | D | Basic and diluted net loss per share, non-redeemable common stock | ||
| Taxes Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Taxes Payable, Current | Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Conversions Of Vendor Liability | 0001829126-25-002289 | 1 | 0 | monetary | D | C | Conversion of vendor liability | |
| Interest Earned On Investments Held In Trust Account | 0001829126-25-002289 | 1 | 0 | monetary | D | C | InterestEarnedOnInvestmentsHeldInTrustAccount | |
| Weighted Average Shares Outstanding Of Nonredeemable Common Stock | 0001829126-25-003897 | 1 | 0 | shares | D | Weighted average shares outstanding of non-redeemable common stock | ||
| Accounts Payable And Accrued Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Payable and Accrued Liabilities, Current | Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits. |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | 0 | 0 | monetary | D | C | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. |
| Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
| Liabilities And Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Retained Earnings Accumulated Deficit | us-gaap/2024 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Weighted Average Shares Outstanding Of Redeemable Common Stock | 0001829126-25-002289 | 1 | 0 | shares | D | Weighted average shares outstanding of redeemable common stock | ||
| Additional Paid In Capital | us-gaap/2024 | 0 | 0 | monetary | I | C | Additional Paid in Capital | Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock. |
| Common Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
| Common Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Income Tax Expense Benefit | us-gaap/2024 | 0 | 0 | monetary | D | D | Income Tax Expense (Benefit) | Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. |
| Net Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Prepaid Expense Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Prepaid Expense, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer. |
| Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Temporary Equity Carrying Amount Attributable To Parent | us-gaap/2024 | 0 | 0 | monetary | I | C | Temporary Equity, Carrying Amount, Attributable to Parent | Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer. |
| Temporary Equity Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Temporary Equity, Shares Authorized | The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer. | |
| Excise Tax Payables Attributable To Redemption Of Common Stock | 0001829126-25-002289 | 1 | 0 | monetary | D | C | ExciseTaxPayablesAttributableToRedemptionOfCommonStock | |
| Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Cash | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation. |
| Common Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Increase Decrease In Accrued Taxes Payable | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accrued Taxes Payable | The increase (decrease) during the reporting period of all taxes owed but not paid, including income, property and other taxes. |
| Increase Decrease In Prepaid Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense | The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods. |
| Interest Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Interest Expense, Operating and Nonoperating | Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense. |
| Interest Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Interest Payable, Current | Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Sales And Excise Tax Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Sales and Excise Tax Payable, Current | Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Basic And Diluted Loss Income Per Share Redeemable Common Stock | 0001829126-25-002289 | 1 | 0 | perShare | D | Basic and diluted income (loss) per share, redeemable common stock | ||
| Conversion Of Vendor Liability Shares | 0001829126-25-002289 | 1 | 0 | shares | D | Conversion of Vendor liability, shares | ||
| Promissory Note | 0001829126-25-002289 | 1 | 0 | monetary | I | C | Promissory note | |
| Increase Decrease In Other Accounts Payable And Accrued Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities | The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid. |
| Accounts Payable And Accrued Expenses | 0001829126-25-003897 | 1 | 0 | monetary | D | C | AccountsPayableAndAccruedExpenses | |
| Promissory Note Related Party | 0001829126-25-003897 | 1 | 0 | monetary | I | C | Promissory note related party | |
| Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Proceeds From Convertible Debt | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Convertible Debt | The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder. |
| Temporary Equity Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Temporary Equity, Par or Stated Value Per Share | Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. | |
| Accretion For Common Stock Subject To Redemption Amount | 0001829126-25-002289 | 1 | 0 | monetary | D | C | Accretion for common stock subject to redemption amount | |
| Weighted Average Shares Outstanding Of Nonredeemable Common Stock | 0001829126-25-002289 | 1 | 0 | shares | D | Weighted average shares outstanding of non-redeemable common stock | ||
| Interest Income Operating | us-gaap/2024 | 0 | 0 | monetary | D | C | Interest Income, Operating | Amount of operating interest income, including, but not limited to, amortization and accretion of premiums and discounts on securities. |
| Increase Decrease In Accrued Income Taxes Payable | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Income Taxes Payable | The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction. |
| Accretion For Common Stock Subject To Redemptions Amount | 0001829126-25-003897 | 1 | 0 | monetary | D | C | AccretionForCommonStockSubjectToRedemptionsAmount | |
| Investments Held In Trust Account | 0001829126-25-003897 | 1 | 0 | monetary | I | D | Investments held in Trust Account | |
| Nonoperating Income Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Nonoperating Income (Expense) | The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). |
| Profit Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. |
| Conversion Of Vendor Liability | 0001829126-25-002289 | 1 | 0 | monetary | D | C | Conversion of Vendor liability | |
| Investment Of Cash Into Trust Account | 0001829126-25-002289 | 1 | 0 | monetary | D | C | InvestmentOfCashIntoTrustAccount | |
| Basic And Diluted Loss Income Per Share Redeemable Common Stock | 0001829126-25-003897 | 1 | 0 | perShare | D | Basic and diluted (loss) income per share, redeemable common stock | ||
| Proceeds From Promissory Note Related Party | 0001829126-25-003897 | 1 | 0 | monetary | D | D | Proceeds from promissory note related party | |
| Weighted Average Shares Outstanding Of Redeemable Common Stock | 0001829126-25-003897 | 1 | 0 | shares | D | Weighted average shares outstanding of redeemable common stock | ||
| Temporary Equity Redemption Price Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Temporary Equity, Redemption Price Per Share | Amount to be paid per share that is classified as temporary equity by entity upon redemption. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer. | |
| Net Cash Provided By Used In Operating Activities | us-gaap/2024 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
| Operating Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
| Conversion Of Promissory Note Payable Shares | 0001829126-25-002289 | 1 | 0 | shares | D | Conversion of Promissory Note payable, shares | ||
| Cash Withdrawn From Trust Account To Pay Franchise And Income Taxes | 0001829126-25-002289 | 1 | 0 | monetary | D | D | Cash withdrawn from Trust Account to pay franchise and income taxes | |
| Repayments Of Debt | us-gaap/2024 | 0 | 0 | monetary | D | C | Repayments of Debt | Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation. |
| Basic And Diluted Net Loss Per Share Nonredeemable Common Stock | 0001829126-25-003897 | 1 | 0 | perShare | D | Basic and diluted net loss per share, non-redeemable common stock | ||
| Deferred Underwriting Fee Payable | 0001829126-25-003897 | 1 | 0 | monetary | I | C | Deferred underwriting fee payable | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Common Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| General And Administrative Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. |
| Conversion Of Promissory Note Payable | 0001829126-25-002289 | 1 | 0 | monetary | D | C | Conversion of Promissory Note payable | |
| Accretion For Common Stock Subject To Redemption Amount | 0001829126-25-003897 | 1 | 0 | monetary | D | C | Accretion for common stock subject to redemption amount | |
| Prepaid Expenses | 0001829126-25-003897 | 1 | 0 | monetary | D | D | PrepaidExpenses | |
| Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Shares, Outstanding | Number of shares issued which are neither cancelled nor held in the treasury. | |
| Common Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Gains Losses On Extinguishment Of Debt | us-gaap/2024 | 0 | 0 | monetary | D | C | Gain (Loss) on Extinguishment of Debt | Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. |
| Net Cash Provided By Used In Financing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
| Conversion Of Convertible Promissory Note Related Party | 0001829126-25-002289 | 1 | 0 | monetary | D | C | Conversion of promissory note related party | |
| Conversion Of Accounts Payable To Promissory Notes | 0001829126-25-002289 | 1 | 0 | monetary | D | C | Conversion of accounts payable to promissory notes | |
| Redemption Of Common Stock | 0001829126-25-002289 | 1 | 0 | monetary | D | C | RedemptionOfCommonStock | |
| Investment Of Cash Into Trust Account | 0001829126-25-003897 | 1 | 0 | monetary | D | C | InvestmentOfCashIntoTrustAccount | |
| Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable and Accrued Liabilities | The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid. |
| Increase Decrease In Income Taxes | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Income Taxes | The increase (decrease) during the reporting period in the amounts payable to taxing authorities for taxes that are based on the reporting entity's earnings, net of amounts receivable from taxing authorities for refunds of overpayments or recoveries of income taxes, and in deferred and other tax liabilities and assets. |
| Net Cash Provided By Used In Investing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Investing Activities | Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. |
| Proceeds From Related Party Debt | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Related Party Debt | The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates. |
| Excise Tax Payable Attributable To Redemption Of Common Stock | 0001829126-25-002289 | 1 | 0 | monetary | D | C | Excise tax payable attributable to redemption of common stock | |
| Promissory Note Related Party | 0001829126-25-002289 | 1 | 0 | monetary | I | C | Promissory note related party | |
| Interest Earned On Investments Held In Trust Account | 0001829126-25-003897 | 1 | 0 | monetary | D | C | InterestEarnedOnInvestmentsHeldInTrustAccount | |
| Assets Held In Trust | us-gaap/2024 | 0 | 0 | monetary | I | D | Asset, Held-in-Trust | The total amount of cash and securities held by third party trustees pursuant to terms of debt instruments or other agreements as of the date of each statement of financial position presented, which can be used by the trustee only to pay the noncurrent portion of specified obligations. |
| Accretion For Common Stock Subject To Redemptions Amount | 0001829126-25-002289 | 1 | 0 | monetary | D | C | AccretionForCommonStockSubjectToRedemptionsAmount | |
| Cash Withdrawn From Trust Account In Connection With Redemption | 0001829126-25-002289 | 1 | 0 | monetary | D | D | Cash withdrawn from Trust Account in connection with redemption |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0001829126-25-002289 | 2 | 3 | BS | 0 | H | Cash | us-gaap/2024 | Cash | 0 |
| 0001829126-25-002289 | 2 | 4 | BS | 0 | H | Prepaid Expense Current | us-gaap/2024 | Prepaid expenses | 0 |
| 0001829126-25-002289 | 2 | 5 | BS | 0 | H | Assets Current | us-gaap/2024 | TOTAL CURRENT ASSETS | 0 |
| 0001829126-25-002289 | 2 | 7 | BS | 0 | H | Assets Held In Trust | us-gaap/2024 | Investments held in Trust Account | 0 |
| 0001829126-25-002289 | 2 | 8 | BS | 0 | H | Assets | us-gaap/2024 | TOTAL ASSETS | 0 |
| 0001829126-25-002289 | 2 | 11 | BS | 0 | H | Accounts Payable And Accrued Liabilities Current | us-gaap/2024 | Accounts payable and accrued expenses | 0 |
| 0001829126-25-002289 | 2 | 12 | BS | 0 | H | Taxes Payable Current | us-gaap/2024 | Income taxes payable | 0 |
| 0001829126-25-002289 | 2 | 13 | BS | 0 | H | Sales And Excise Tax Payable Current | us-gaap/2024 | Excise taxes payable | 0 |
| 0001829126-25-002289 | 2 | 14 | BS | 0 | H | Promissory Note | 0001829126-25-002289 | Promissory note | 0 |
| 0001829126-25-002289 | 2 | 15 | BS | 0 | H | Promissory Note Related Party | 0001829126-25-002289 | Promissory note related party | 0 |
| 0001829126-25-002289 | 2 | 16 | BS | 0 | H | Interest Payable Current | us-gaap/2024 | Interest payable | 0 |
| 0001829126-25-002289 | 2 | 17 | BS | 0 | H | Liabilities Current | us-gaap/2024 | TOTAL CURRENT LIABILITIES | 0 |
| 0001829126-25-002289 | 2 | 19 | BS | 0 | H | Deferred Compensation Liability Classified Noncurrent | us-gaap/2024 | Deferred underwriting fee payable | 0 |
| 0001829126-25-002289 | 2 | 20 | BS | 0 | H | Liabilities | us-gaap/2024 | TOTAL LIABILITIES | 0 |
| 0001829126-25-002289 | 2 | 21 | BS | 0 | H | Temporary Equity Carrying Amount Attributable To Parent | us-gaap/2024 | Common stock subject to possible redemption, $0.0001 par value, 101,104 and 519,321 shares at redemption value of $11.51 and $10.74 per share as of December 31, 2024 and 2023, respectively | 0 |
| 0001829126-25-002289 | 2 | 23 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Common Stock; $0.0001 par value; 30,000,000 shares authorized; 2,800,900 and 2,650,900 issued and outstanding (excluding 101,104 and 519,321 shares subject to possible redemption) as of December 31, 2024 and 2023, respectively | 0 |
| 0001829126-25-002289 | 2 | 24 | BS | 0 | H | Additional Paid In Capital | us-gaap/2024 | Additional paid-in capital | 0 |
| 0001829126-25-002289 | 2 | 25 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Accumulated deficit | 0 |
| 0001829126-25-002289 | 2 | 26 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | TOTAL STOCKHOLDERS DEFICIT | 0 |
| 0001829126-25-002289 | 2 | 27 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | TOTAL LIABILITIES AND STOCKHOLDERS DEFICIT | 0 |
| 0001829126-25-002289 | 3 | 1 | BS | 1 | H | Temporary Equity Par Or Stated Value Per Share | us-gaap/2024 | Common stock subject to possible redemption, par value | 0 |
| 0001829126-25-002289 | 3 | 2 | BS | 1 | H | Temporary Equity Shares Authorized | us-gaap/2024 | Common stock subject to possible redemption | 0 |
| 0001829126-25-002289 | 3 | 3 | BS | 1 | H | Temporary Equity Redemption Price Per Share | us-gaap/2024 | Common stock subject to possible redemption, per share | 0 |
| 0001829126-25-002289 | 3 | 4 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2024 | Common stock, par value | 0 |
| 0001829126-25-002289 | 3 | 5 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2024 | Common stock, shares authorized | 0 |
| 0001829126-25-002289 | 3 | 6 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2024 | Common stock, shares issued | 0 |
| 0001829126-25-002289 | 3 | 7 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2024 | Common stock, shares outstanding | 0 |
| 0001829126-25-002289 | 4 | 1 | IS | 0 | H | General And Administrative Expense | us-gaap/2024 | General and administrative expenses | 0 |
| 0001829126-25-002289 | 4 | 2 | IS | 0 | H | Operating Income Loss | us-gaap/2024 | Loss from operations | 0 |
| 0001829126-25-002289 | 4 | 4 | IS | 0 | H | Interest Income Operating | us-gaap/2024 | Interest earned on investments held in Trust Account | 0 |
| 0001829126-25-002289 | 4 | 5 | IS | 0 | H | Interest Expense | us-gaap/2024 | Interest expense | 1 |
| 0001829126-25-002289 | 4 | 6 | IS | 0 | H | Gains Losses On Extinguishment Of Debt | us-gaap/2024 | Forgiveness of debt | 0 |
| 0001829126-25-002289 | 4 | 7 | IS | 0 | H | Nonoperating Income Expense | us-gaap/2024 | Total other income, net | 0 |
| 0001829126-25-002289 | 4 | 8 | IS | 0 | H | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | Loss before provision for income taxes | 0 |
| 0001829126-25-002289 | 4 | 9 | IS | 0 | H | Income Tax Expense Benefit | us-gaap/2024 | Provision for income taxes | 1 |
| 0001829126-25-002289 | 4 | 10 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001829126-25-002289 | 4 | 11 | IS | 0 | H | Weighted Average Shares Outstanding Of Redeemable Common Stock | 0001829126-25-002289 | Weighted average shares outstanding of redeemable common stock | 0 |
| 0001829126-25-002289 | 4 | 12 | IS | 0 | H | Basic And Diluted Loss Income Per Share Redeemable Common Stock | 0001829126-25-002289 | Basic and diluted income (loss) per share, redeemable common stock | 0 |
| 0001829126-25-002289 | 4 | 13 | IS | 0 | H | Weighted Average Shares Outstanding Of Nonredeemable Common Stock | 0001829126-25-002289 | Weighted average shares outstanding of non-redeemable common stock | 0 |
| 0001829126-25-002289 | 4 | 14 | IS | 0 | H | Basic And Diluted Net Loss Per Share Nonredeemable Common Stock | 0001829126-25-002289 | Basic and diluted net loss per share, non-redeemable common stock | 0 |
| 0001829126-25-002289 | 5 | 8 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance December 31, 2023 | 0 |
| 0001829126-25-002289 | 5 | 9 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Beginning balance, shares | 0 |
| 0001829126-25-002289 | 5 | 10 | EQ | 0 | H | Accretion For Common Stock Subject To Redemption Amount | 0001829126-25-002289 | Accretion for common stock subject to redemption amount | 0 |
| 0001829126-25-002289 | 5 | 11 | EQ | 0 | H | Excise Tax Payable Attributable To Redemption Of Common Stock | 0001829126-25-002289 | Excise tax payable attributable to redemption of common stock | 0 |
| 0001829126-25-002289 | 5 | 12 | EQ | 0 | H | Conversion Of Promissory Note Payable | 0001829126-25-002289 | Conversion of Promissory Note payable | 0 |
| 0001829126-25-002289 | 5 | 13 | EQ | 0 | H | Conversion Of Promissory Note Payable Shares | 0001829126-25-002289 | Conversion of Promissory Note payable, shares | 0 |
| 0001829126-25-002289 | 5 | 14 | EQ | 0 | H | Conversion Of Vendor Liability | 0001829126-25-002289 | Conversion of Vendor liability | 0 |
| 0001829126-25-002289 | 5 | 15 | EQ | 0 | H | Conversion Of Vendor Liability Shares | 0001829126-25-002289 | Conversion of Vendor liability, shares | 0 |
| 0001829126-25-002289 | 5 | 16 | EQ | 0 | H | Profit Loss | us-gaap/2024 | Net loss | 0 |
| 0001829126-25-002289 | 5 | 17 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance December 31, 2024 | 0 |
| 0001829126-25-002289 | 5 | 18 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Ending balance, shares | 0 |
| 0001829126-25-003897 | 2 | 12 | BS | 0 | H | Taxes Payable Current | us-gaap/2024 | Income taxes payable | 0 |
| 0001829126-25-003897 | 2 | 3 | BS | 0 | H | Cash | us-gaap/2024 | Cash | 0 |
| 0001829126-25-003897 | 2 | 4 | BS | 0 | H | Prepaid Expense Current | us-gaap/2024 | Prepaid expenses | 0 |
| 0001829126-25-003897 | 2 | 5 | BS | 0 | H | Assets Current | us-gaap/2024 | TOTAL CURRENT ASSETS | 0 |
| 0001829126-25-003897 | 2 | 7 | BS | 0 | H | Investments Held In Trust Account | 0001829126-25-003897 | Investments held in Trust Account | 0 |
| 0001829126-25-003897 | 2 | 8 | BS | 0 | H | Assets | us-gaap/2024 | TOTAL ASSETS | 0 |
| 0001829126-25-003897 | 2 | 11 | BS | 0 | H | Accounts Payable And Accrued Liabilities Current | us-gaap/2024 | Accounts payable and accrued expenses | 0 |
| 0001829126-25-003897 | 2 | 13 | BS | 0 | H | Sales And Excise Tax Payable Current | us-gaap/2024 | Excise taxes payable | 0 |
| 0001829126-25-003897 | 2 | 14 | BS | 0 | H | Promissory Note Related Party | 0001829126-25-003897 | Promissory note related party | 0 |
| 0001829126-25-003897 | 2 | 15 | BS | 0 | H | Liabilities Current | us-gaap/2024 | TOTAL CURRENT LIABILITIES | 0 |
| 0001829126-25-003897 | 2 | 16 | BS | 0 | H | Deferred Underwriting Fee Payable | 0001829126-25-003897 | Deferred underwriting fee payable | 0 |
| 0001829126-25-003897 | 2 | 17 | BS | 0 | H | Liabilities | us-gaap/2024 | TOTAL LIABILITIES | 0 |
| 0001829126-25-003897 | 2 | 18 | BS | 0 | H | Temporary Equity Carrying Amount Attributable To Parent | us-gaap/2024 | Common stock subject to possible redemption, $0.0001 par value, 101,104 shares at redemption value of $11.54 and $11.51 per share as of March 31, 2025 and December 31, 2024, respectively | 0 |
| 0001829126-25-003897 | 2 | 20 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Common Stock; $0.0001 par value; 30,000,000 shares authorized; 2,800,900 issued and outstanding (excluding 101,104 shares subject to possible redemption) as of March 31, 2025 and December 31, 2024 | 0 |
| 0001829126-25-003897 | 2 | 21 | BS | 0 | H | Additional Paid In Capital | us-gaap/2024 | Additional paid-in capital | 0 |
| 0001829126-25-003897 | 2 | 22 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Accumulated deficit | 0 |
| 0001829126-25-003897 | 2 | 23 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | TOTAL STOCKHOLDERS DEFICIT | 0 |
| 0001829126-25-003897 | 2 | 24 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | TOTAL LIABILITIES AND STOCKHOLDERS DEFICIT | 0 |
| 0001829126-25-003897 | 3 | 1 | BS | 1 | H | Temporary Equity Par Or Stated Value Per Share | us-gaap/2024 | Common stock subject to possible redemption, par value | 0 |
| 0001829126-25-003897 | 3 | 2 | BS | 1 | H | Temporary Equity Shares Authorized | us-gaap/2024 | Common stock subject to possible redemption | 0 |
| 0001829126-25-003897 | 3 | 3 | BS | 1 | H | Temporary Equity Redemption Price Per Share | us-gaap/2024 | Common stock subject to possible redemption, per share | 0 |
| 0001829126-25-003897 | 3 | 4 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2024 | Common stock, par value | 0 |
| 0001829126-25-003897 | 3 | 5 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2024 | Common stock, shares authorized | 0 |
| 0001829126-25-003897 | 3 | 6 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2024 | Common stock, shares issued | 0 |
| 0001829126-25-003897 | 3 | 7 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2024 | Common stock, shares outstanding | 0 |
| 0001829126-25-003897 | 4 | 1 | IS | 0 | H | General And Administrative Expense | us-gaap/2024 | General and administrative expenses | 0 |
| 0001829126-25-003897 | 4 | 2 | IS | 0 | H | Operating Income Loss | us-gaap/2024 | Loss from operations | 0 |
| 0001829126-25-003897 | 4 | 4 | IS | 0 | H | Interest Income Operating | us-gaap/2024 | Interest earned on investments held in Trust Account | 0 |
| 0001829126-25-003897 | 4 | 5 | IS | 0 | H | Interest Expense | us-gaap/2024 | Interest expense | 1 |
| 0001829126-25-003897 | 4 | 6 | IS | 0 | H | Nonoperating Income Expense | us-gaap/2024 | Total other income (loss), net | 0 |
| 0001829126-25-003897 | 4 | 7 | IS | 0 | H | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | Loss before provision for income taxes | 0 |
| 0001829126-25-003897 | 4 | 8 | IS | 0 | H | Income Tax Expense Benefit | us-gaap/2024 | Provision for income taxes | 1 |
| 0001829126-25-003897 | 4 | 9 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001829126-25-003897 | 4 | 10 | IS | 0 | H | Weighted Average Shares Outstanding Of Redeemable Common Stock | 0001829126-25-003897 | Weighted average shares outstanding of redeemable common stock | 0 |
| 0001829126-25-003897 | 4 | 11 | IS | 0 | H | Basic And Diluted Loss Income Per Share Redeemable Common Stock | 0001829126-25-003897 | Basic and diluted (loss) income per share, redeemable common stock | 0 |
| 0001829126-25-003897 | 4 | 12 | IS | 0 | H | Weighted Average Shares Outstanding Of Nonredeemable Common Stock | 0001829126-25-003897 | Weighted average shares outstanding of non-redeemable common stock | 0 |
| 0001829126-25-003897 | 4 | 13 | IS | 0 | H | Basic And Diluted Net Loss Per Share Nonredeemable Common Stock | 0001829126-25-003897 | Basic and diluted net loss per share, non-redeemable common stock | 0 |
| 0001829126-25-003897 | 5 | 8 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance January 1, 2024 | 0 |
| 0001829126-25-003897 | 5 | 9 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Beginning balance, shares | 0 |
| 0001829126-25-003897 | 5 | 10 | EQ | 0 | H | Accretion For Common Stock Subject To Redemption Amount | 0001829126-25-003897 | Accretion for common stock subject to redemption amount | 0 |
| 0001829126-25-003897 | 5 | 11 | EQ | 0 | H | Profit Loss | us-gaap/2024 | Net loss | 0 |
| 0001829126-25-003897 | 5 | 12 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance March 31, 2024 | 0 |
| 0001829126-25-003897 | 5 | 13 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Ending balance, shares | 0 |
| 0001829126-25-003897 | 6 | 2 | CF | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001829126-25-003897 | 6 | 4 | CF | 0 | H | Interest Earned On Investments Held In Trust Account | 0001829126-25-003897 | Interest earned on investments held in Trust Account | 1 |
| 0001829126-25-003897 | 6 | 5 | CF | 0 | H | Interest Expense | us-gaap/2024 | Interest expense | 0 |
| 0001829126-25-003897 | 6 | 6 | CF | 0 | H | Increase Decrease In Prepaid Expense | us-gaap/2024 | Prepaid expenses | 1 |
| 0001829126-25-003897 | 6 | 7 | CF | 0 | H | Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2024 | Accounts payable and accrued expenses | 0 |
| 0001829126-25-003897 | 6 | 8 | CF | 0 | H | Increase Decrease In Accrued Taxes Payable | us-gaap/2024 | Excise tax payable | 0 |
| 0001829126-25-003897 | 6 | 9 | CF | 0 | H | Increase Decrease In Accrued Income Taxes Payable | us-gaap/2024 | Income taxes payable | 0 |
| 0001829126-25-003897 | 6 | 10 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | Net cash used in operating activities | 0 |
| 0001829126-25-003897 | 6 | 12 | CF | 0 | H | Investment Of Cash Into Trust Account | 0001829126-25-003897 | Investment of cash into Trust Account | 1 |
| 0001829126-25-003897 | 6 | 13 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2024 | Net cash used in investing activities | 0 |
| 0001829126-25-003897 | 6 | 15 | CF | 0 | H | Proceeds From Promissory Note Related Party | 0001829126-25-003897 | Proceeds from promissory note related party | 0 |
| 0001829126-25-003897 | 6 | 16 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2024 | Net cash provided by financing activities | 0 |
| 0001829126-25-003897 | 6 | 17 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | us-gaap/2024 | Net Change in Cash | 0 |
| 0001829126-25-003897 | 6 | 18 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash Beginning of period | 0 |
| 0001829126-25-003897 | 6 | 19 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash End of period | 0 |
| 0001829126-25-003897 | 6 | 21 | CF | 0 | H | Accretion For Common Stock Subject To Redemptions Amount | 0001829126-25-003897 | Accretion for common stock subject to redemption amount | 0 |
| 0001829126-25-003897 | 6 | 22 | CF | 0 | H | Prepaid Expenses | 0001829126-25-003897 | Prepaid expenses | 0 |
| 0001829126-25-003897 | 6 | 23 | CF | 0 | H | Accounts Payable And Accrued Expenses | 0001829126-25-003897 | Accounts payable and accrued expenses | 0 |
| 0001829126-25-002289 | 6 | 2 | CF | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001829126-25-002289 | 6 | 4 | CF | 0 | H | Interest Earned On Investments Held In Trust Account | 0001829126-25-002289 | Interest earned on investments held in Trust Account | 1 |
| 0001829126-25-002289 | 6 | 5 | CF | 0 | H | Interest Expense | us-gaap/2024 | Interest expense | 0 |
| 0001829126-25-002289 | 6 | 6 | CF | 0 | H | Gains Losses On Extinguishment Of Debt | us-gaap/2024 | Forgiveness of debt | 1 |
| 0001829126-25-002289 | 6 | 7 | CF | 0 | H | Increase Decrease In Prepaid Expense | us-gaap/2024 | Prepaid expenses | 1 |
| 0001829126-25-002289 | 6 | 8 | CF | 0 | H | Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2024 | Accounts payable and accrued expenses | 0 |
| 0001829126-25-002289 | 6 | 9 | CF | 0 | H | Increase Decrease In Accrued Taxes Payable | us-gaap/2024 | Excise tax payable | 0 |
| 0001829126-25-002289 | 6 | 10 | CF | 0 | H | Increase Decrease In Income Taxes | us-gaap/2024 | Income taxes payable | 0 |
| 0001829126-25-002289 | 6 | 11 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | Net cash used in operating activities | 0 |
| 0001829126-25-002289 | 6 | 13 | CF | 0 | H | Investment Of Cash Into Trust Account | 0001829126-25-002289 | Investment of cash into Trust Account | 1 |
| 0001829126-25-002289 | 6 | 14 | CF | 0 | H | Cash Withdrawn From Trust Account To Pay Franchise And Income Taxes | 0001829126-25-002289 | Cash withdrawn from Trust Account to pay franchise and income taxes | 0 |
| 0001829126-25-002289 | 6 | 15 | CF | 0 | H | Cash Withdrawn From Trust Account In Connection With Redemption | 0001829126-25-002289 | Cash withdrawn from Trust Account in connection with redemption | 0 |
| 0001829126-25-002289 | 6 | 16 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2024 | Net cash provided by investing activities | 0 |
| 0001829126-25-002289 | 6 | 18 | CF | 0 | H | Repayments Of Debt | us-gaap/2024 | Repayment of promissory note | 1 |
| 0001829126-25-002289 | 6 | 19 | CF | 0 | H | Proceeds From Related Party Debt | us-gaap/2024 | Proceeds from promissory note related party | 0 |
| 0001829126-25-002289 | 6 | 20 | CF | 0 | H | Proceeds From Convertible Debt | us-gaap/2024 | Proceeds from convertible promissory note related party | 0 |
| 0001829126-25-002289 | 6 | 21 | CF | 0 | H | Redemption Of Common Stock | 0001829126-25-002289 | Redemption of common stock | 1 |
| 0001829126-25-002289 | 6 | 22 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2024 | Net cash used in financing activities | 0 |
| 0001829126-25-002289 | 6 | 23 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | us-gaap/2024 | Net Change in Cash | 0 |
| 0001829126-25-002289 | 6 | 24 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash Beginning of period | 0 |
| 0001829126-25-002289 | 6 | 25 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash End of period | 0 |
| 0001829126-25-002289 | 6 | 27 | CF | 0 | H | Accretion For Common Stock Subject To Redemptions Amount | 0001829126-25-002289 | Accretion for common stock subject to redemption amount | 0 |
| 0001829126-25-002289 | 6 | 28 | CF | 0 | H | Excise Tax Payables Attributable To Redemption Of Common Stock | 0001829126-25-002289 | Excise tax payable attributable to redemption of common stock | 0 |
| 0001829126-25-002289 | 6 | 29 | CF | 0 | H | Conversion Of Accounts Payable To Promissory Notes | 0001829126-25-002289 | Conversion of accounts payable to promissory notes | 0 |
| 0001829126-25-002289 | 6 | 30 | CF | 0 | H | Conversion Of Convertible Promissory Note Related Party | 0001829126-25-002289 | Conversion of promissory note related party | 0 |
| 0001829126-25-002289 | 6 | 31 | CF | 0 | H | Conversions Of Vendor Liability | 0001829126-25-002289 | Conversion of vendor liability | 0 |
| 0001829126-25-002289 | 6 | 32 | CF | 0 | H | Increase Decrease In Prepaid Expenses Other | us-gaap/2024 | Prepaid expenses | 0 |
| 0001829126-25-002289 | 6 | 33 | CF | 0 | H | Increase Decrease In Other Accounts Payable And Accrued Liabilities | us-gaap/2024 | Accounts payable and accrued expenses | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |